CERS
Price
$1.54
Change
-$0.02 (-1.28%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
342.62M
28 days until earnings call
UTMD
Price
$58.44
Change
+$0.95 (+1.65%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
255.21M
Interact to see
Advertisement

CERS vs UTMD

Header iconCERS vs UTMD Comparison
Open Charts CERS vs UTMDBanner chart's image
Cerus
Price$1.54
Change-$0.02 (-1.28%)
Volume$77.1K
Capitalization342.62M
Utah Medical Products
Price$58.44
Change+$0.95 (+1.65%)
Volume$551
Capitalization255.21M
CERS vs UTMD Comparison Chart in %
Loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERS vs. UTMD commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a Buy and UTMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (CERS: $1.54 vs. UTMD: $58.44)
Brand notoriety: CERS and UTMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CERS: 32% vs. UTMD: 54%
Market capitalization -- CERS: $342.62M vs. UTMD: $255.21M
CERS [@Medical Specialties] is valued at $342.62M. UTMD’s [@Medical Specialties] market capitalization is $255.21M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileUTMD’s FA Score has 1 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • UTMD’s FA Score: 1 green, 4 red.
According to our system of comparison, UTMD is a better buy in the long-term than CERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 5 TA indicator(s) are bullish while UTMD’s TA Score has 6 bullish TA indicator(s).

  • CERS’s TA Score: 5 bullish, 4 bearish.
  • UTMD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, UTMD is a better buy in the short-term than CERS.

Price Growth

CERS (@Medical Specialties) experienced а +13.24% price change this week, while UTMD (@Medical Specialties) price change was +3.54% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

CERS is expected to report earnings on Jul 31, 2025.

UTMD is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CERS($343M) has a higher market cap than UTMD($255M). CERS YTD gains are higher at: 0.000 vs. UTMD (-3.888). UTMD has higher annual earnings (EBITDA): 23.1M vs. CERS (-26.34M). UTMD has more cash in the bank: 92.9M vs. CERS (65.9M). UTMD has less debt than CERS: UTMD (295K) vs CERS (96M). CERS has higher revenues than UTMD: CERS (156M) vs UTMD (50.2M).
CERSUTMDCERS / UTMD
Capitalization343M255M135%
EBITDA-26.34M23.1M-114%
Gain YTD0.000-3.888-
P/E RatioN/A15.45-
Revenue156M50.2M311%
Total Cash65.9M92.9M71%
Total Debt96M295K32,542%
FUNDAMENTALS RATINGS
CERS vs UTMD: Fundamental Ratings
CERS
UTMD
OUTLOOK RATING
1..100
242
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
11
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9665
PRICE GROWTH RATING
1..100
5157
P/E GROWTH RATING
1..100
10055
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UTMD's Valuation (11) in the Medical Specialties industry is somewhat better than the same rating for CERS (45). This means that UTMD’s stock grew somewhat faster than CERS’s over the last 12 months.

UTMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as CERS (100). This means that UTMD’s stock grew similarly to CERS’s over the last 12 months.

UTMD's SMR Rating (65) in the Medical Specialties industry is in the same range as CERS (96). This means that UTMD’s stock grew similarly to CERS’s over the last 12 months.

CERS's Price Growth Rating (51) in the Medical Specialties industry is in the same range as UTMD (57). This means that CERS’s stock grew similarly to UTMD’s over the last 12 months.

UTMD's P/E Growth Rating (55) in the Medical Specialties industry is somewhat better than the same rating for CERS (100). This means that UTMD’s stock grew somewhat faster than CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSUTMD
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
56%
Declines
ODDS (%)
Bearish Trend 21 days ago
84%
Bearish Trend 14 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
63%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GXYYY23.760.12
+0.51%
Galaxy Entertainment Group, Ltd.
ESYJY7.20N/A
N/A
easyJet Plc
CCHI0.17N/A
N/A
Cambridge Capital Holdings, Inc.
SBOEF33.47N/A
N/A
Schoeller Bleckmann Oilfield Equipment AG
GASXF0.69-0.02
-3.27%
NG Energy International Corp.

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with LAB. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then LAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
-1.28%
LAB - CERS
53%
Loosely correlated
-1.46%
NNOX - CERS
47%
Loosely correlated
-0.19%
SGHT - CERS
46%
Loosely correlated
+1.20%
UTMD - CERS
46%
Loosely correlated
+1.66%
ICUI - CERS
45%
Loosely correlated
-0.54%
More

UTMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTMD has been loosely correlated with ALGN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if UTMD jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTMD
1D Price
Change %
UTMD100%
+1.66%
ALGN - UTMD
48%
Loosely correlated
-0.08%
ITGR - UTMD
47%
Loosely correlated
-0.16%
CERS - UTMD
46%
Loosely correlated
-1.28%
TMCI - UTMD
44%
Loosely correlated
+1.48%
AVNS - UTMD
43%
Loosely correlated
-0.24%
More